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INTRODUCTION
Myocardial progenitors are derived from early migratory
mesoderm that forms bilateral heart fields. These populations
organize and coalesce generating the heart field crescent
immediately rostral to the forming anterior intestinal portal in the
mouse. Through a combination of proliferation and reorganization
of the lateral fields, a subset of these myocardial progenitors form
the primary heart tube (reviewed by Abu-Issa et al., 2004; Harvey,
2002). The primary heart tube gives rise to the cardiac inflow tract
(atria) and the left ventricle. The remaining chambers of the heart,
specifically the cardiac outflow tract (OT) and the right ventricle
(RV) are derived from the pharyngeal mesoderm contiguous with
the primary heart tube. Recent studies in chick and mouse
demonstrate that cells within the developing splanchnic mesoderm
(SM), as well as possibly the pharyngeal arch core mesoderm
(CM), migrate from the pharynx and contribute to the myocardial
wall of the OT and RV during early stages of development (Kelly
et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001). These
myocardial precursors have been defined as the anterior heart field
(AHF), which we use to describe specifically the SM and CM that
contribute to the myocardium of the OT and RV.
In more recent studies, several transcription factors (Isl1, Tbx1,
Nkx2.5, Foxh1, Mef2c) and extracellular signaling molecules (SHH,
FGF10, BMP4) that are expressed within or adjacent to the SM
and CM have been functionally implicated in AHF development
(Baldini, 2004; Cai et al., 2003; Dodou et al., 2004; Lyons et al.,
1995; Hu et al., 2004; Jiao et al., 2003; Kelly et al., 2001; Liu et al.,
2004; von Both et al., 2004; Xu et al., 2004) (Washington Smoak et
al., 2005). Moreover, extensive genetic analyses have shed some
light on the regulatory network that guides its development. For
example, Shh has been implicated as a regulator of Tbx1 expression
through the Foxa1, Foxc1 and Foxc2 transcription factors
(Yamagishi et al., 2003), and Tbx1 in turn may regulate Fgf8
expression (Hu et al., 2004). Interestingly, heterozygosity for Fgf8
increases the incidence of cardiac defects of Tbx1+/– embryos (Hu
et al., 2004; Vitelli et al., 2002) and Fgf8 hypomorphic mutants
have OT defects, such as double outlet right ventricle and persistent
truncus arteriosus (Abu-Issa et al., 2002; Frank et al., 2002).
Fgf8 is a member of a large gene family encoding extracellular
ligands that have a wide range of cellular effects depending on the
developmental context. Several studies have indicated that there
are at least four non-mutually exclusive roles for Fgf8 in the
development of OT defects. First, there is a primary requirement
for Fgf8 during gastrulation, and loss of Fgf8 results in failure to
form a crescent of heart precursor cells (Sun et al., 1999). Second,
Fgf8 is required for establishing the left-right axis and cardiac
looping. Abnormalities in this process may affect OT development
(Albertson and Yelick, 2005; Meyers and Martin, 1999). Third,
Fgf8 is required for migratory cardiac neural crest cell survival,
and therefore OT septation defects could arise from neural crest
cell deficiencies (Abu-Issa et al., 2002; Macatee et al., 2003).
Finally, Fgf8 is expressed in the precardiac SM as early as E7.75
(Crossley and Martin, 1995; Kelly et al., 2001) and could have a
direct role in AHF maintenance and/or specification. Reduction
of the AHF population, and subsequent shortening of the OT,
could result in OT septation defects. In zebrafish, it has been
demonstrated that the loss of fgf8 results in the severe truncation
of the ventricular myocardial segment (Reifers et al., 2000).
In this study, we have used genetic manipulations to distinguish
between these possibilities to better understand how Fgf8 regulates
OT development. We find that Fgf8 is required for AHF proliferation
and survival; furthermore, we define the responsive tissues as well as
the expression domains of Fgf8 that are crucial for AHF development.
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In the mouse embryo, the splanchnic mesodermal cells of the anterior heart field (AHF) migrate from the pharynx to contribute to
the early myocardium of the outflow tract (OT) and right ventricle (RV). Recent studies have attempted to distinguish the AHF from
other precardiac populations, and to determine the genetic and molecular mechanisms that regulate its development. Here, we
have used an Fgf8lacZ allele to demonstrate that Fgf8 is expressed within the developing AHF. In addition, we use both a
hypomorphic Fgf8 allele (Fgf8neo) and Cre-mediated gene ablation to show that Fgf8 is essential for the survival and proliferation of
the AHF. Nkx2.5Cre is expressed in the AHF, primary heart tube and pharyngeal endoderm, while TnT-Cre is expressed only within the
specified heart tube myocardium. Deletion of Fgf8 by Nkx2.5Cre results in a significant loss of the Nkx2.5Cre lineage and severe OT
and RV truncations by E9.5, while the remaining heart chambers (left ventricle and atria) are grossly normal. These defects result
from significant decreases in cell proliferation and aberrant cell death in both the pharyngeal endoderm and splanchnic mesoderm.
By contrast, ablation of Fgf8 in the TnT-Cre domain does not result in OT or RV defects, providing strong evidence that Fgf8
expression is crucial in the pharyngeal endoderm and/or overlying splanchnic mesoderm of the AHF at a stage prior to heart tube
elongation. Analysis of downstream signaling components, such as phosphorylated-Erk and Pea3, identifies the AHF splanchnic
mesoderm itself as a target for Fgf8 signaling.
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MATERIALS AND METHODS
Mouse lines
All mouse lines used in this study were maintained on mixed genetic
backgrounds. Floxed, null and hypomorphic alleles of Fgf8 (respectively
named Fgf8flox, Fgf8– and Fgf8neo) have been previously described
(Meyers et al., 1998). The Fgf8lacZ ‘knock in’ line was used to follow Fgf8
gene expression and was used interchangeably as a null allele (D.B. and
G. R. Martin, unpublished). Nkx2.5Cre (Moses et al., 2001) and TnT-Cre
(Jiao et al., 2003) were crossed to the Cre-reporter line Rosa26R (R26R)
(Soriano, 1999) to determine the domains of DNA recombination as
shown by -galactosidase (-gal) activity in the progeny. Bmp4lacZ and
Ptch1lacZ lines have been described previously (Goodrich et al., 1996;
Lawson et al., 1999).
Generation of Cre-mediated Fgf8-null mutants
To generate Nkx2.5Cre/+; Fgf8flox/– embryos, male mice heterozygous for
Nkx2.5Cre and Fgf8 were mated to females homozygous for the Fgf8 floxed
allele (Fgf8flox/flox). The embryos were genotyped for Cre and Fgf8 alleles
as previously described (Meyers et al., 1998; Sun et al., 2002). Similar
strategies were used to generate Nkx2.5Cre/+; Fgf8flox/lacZ and TnT-Cre;
Fgf8flox/lacZ mutant embryos. For Cre lineage trace analysis in the conditional
mutant background, Nkx2.5Cre/+; Fgf8+/– males were crossed to females
homozygous for both Fgf8flox and R26R. Fgf8lacZ, Ptch1lacZ and Bmp4lacZ
embryos were genotyped for lacZ by staining for -gal activity as described
below.
lacZ staining
For embryos containing the R26R reporter allele or Bmp4lacZ, tissues were
fixed for 20 minutes at room temperature in 2% formaldehyde/0.2%
glutaraldehyde in PBS with 0.02% NP40, then stained overnight at 37°C in
standard X-gal stain. For Fgf8lacZ and Ptch1lacZ embryos, tissues were fixed
for 2-3 minutes at room temperature, followed by standard X-gal stain for
48 to 72 hours at 37°C.
In situ hybridization
Digoxigenin antisense riboprobes were synthesized using template plasmids
described in the following: Fgf8 (Crossley and Martin, 1995), Wnt11
(Majumdar et al., 2003), Anf, Mhc, Mlc2v (Christoffels et al., 2000) and Pea3
(Firnberg and Neubuser, 2002). Whole-mount mRNA in situ hybridization
was performed essentially as previously described (Neubuser et al., 1997).
All results represent at least three mutants and three control embryos.
Immunohistochemistry
All antibodies were diluted in blocking solution containing 3% milk, 0.1%
Triton X in PBS. Antibodies were diluted as indicated: phospho-Histone H3
(1:500; Upstate Biotechnology), phospho-Erk (1:200; Cell Signaling
Technologies) and AP2 (1:100; Developmental Studies Hybridoma Bank).
Alexa Fluor 594 anti-rabbit IgG (Molecular Probes) and Cy2 anti-mouse
IgG (Jackson Immuno) secondary antibodies were diluted 1:500. pErk
staining was amplified with 1:200 biotinylated anti-rabbit IgG (Vector
Laboratories), followed by 1:50 HRP-streptavidin (Jackson Immuno). For
peroxidase colorimetric detection, embryos were bleached in 3% H2O2 in
PBS, and incubated for 10 minutes at room temperature in 0.67 mg/ml 3,3-
diaminobenzidine (DAB, Sigma) in PBS containing 0.1% Tween 20.
Cell death
LysoTracker Red (Molecular Probes) staining has been previously described
as a marker for cells death (Zucker et al., 1999). We have performed
LysoTracker Red staining as described by Abu-Issa et al. (Abu-Issa et al.,
2002), with the exception that DMEM was substituted for Lactated Ringer’s
Solution.
RESULTS
Fgf8 hypomorphic embryos exhibit cardiovascular
and craniofacial defects
Previous analyses of Fgf8 hypomorphic mutants with variable levels
of Fgf8 expression have revealed a range of cardiovascular
phenotypes (Abu-Issa et al., 2002; Frank et al., 2002). Eighty-five
percent of Fgf8neo/– hypomorphic mutants survive to term with
various cardiac defects. Approximately 50% of these embryos have
abnormal left-right axis establishment (data not shown), based on
earlier ratios of laterality markers as well as organ laterality at term
(Meyers and Martin, 1999). The remaining survivors exhibit severe
craniofacial and cardiovascular defects, such as double outlet right
ventricle (data not shown). These defects are reminiscent of
DiGeorge/Velocardiofacial Syndrome and appear statistically and
phenotypically independent of left-right defects. Instead, these
defects are consistent with significant losses of neural crest cells
(Abu-Issa et al., 2002; Macatee et al., 2003) and possibly
deficiencies in AHF development.
In order to determine whether defects in the AHF contribute to
these observed phenotypes, we examined Fgf8neo/– and Fgf8neo/lacZ
embryos for OT or RV abnormalities at embryonic day (E) 9.5,
prior to any substantial contribution of neural crest cell (NCC)-
derived populations. Most of the mutant embryos that survive early
gastrulation defects exhibit moderate (Fig. 1C) or severe (Fig. 1D)
truncations of the OT and RV when compared with stage-matched
controls (Fig. 1A). Most of these moderate and severe mutants
presumably die by E10.5 owing to circulation failure, as evidenced
by pericardial edema (data not shown). The remaining
hypomorphic mutants demonstrate mild truncation of the OT/RV
(Fig. 1B). These mild Fgf8neo/– mutants presumably progress to
term with a variety of OT defects such as double outlet right
ventricle, which may be the result of the OT/RV hypoplasia. No
defects in the atria or left ventricle were evident in our analysis at
this stage.
Surprisingly, we noted strong -gal activity in the developing OT
and RV of Fgf8+/lacZ embryos at E9.5-E10.5, where Fgf8 mRNA has
not previously been detected. This expression pattern is consistent
with a transgenic Fgf8-lacZ line which has detectable -gal activity
in the OT (Hu et al., 2004). Given the abnormal OT/RV phenotype
and this unexpected expression, we compared the expression of both
Fgf8 mRNA and Fgf8lacZ relative to AHF development. Fgf8lacZ
faithfully recapitulates Fgf8 mRNA expression pattern in all areas
examined between E7.5 and E10.5 with some notable differences
described below.
Analysis of Fgf8 expression relative to heart
development
At E7.75, both Fgf8 mRNA and Fgf8lacZ expression are present in
bilateral fields immediately caudal to the primary heart field
(Crossley and Martin, 1995). These cells ingress inward with the
foregut pocket, moving both dorsally and rostrally in relation to the
primary heart field. Consistent with this model, both Fgf8 mRNA
and Fgf8lacZ are expressed in the SM contiguous with the developing
OT between E8.0 and E8.5. (Fig. 2C,C and 2D,D, respectively).
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Fig. 1. Fgf8 hypomorphs have variable length outflow tracts.
(A-D) Fgf8neo/lacZ embryos that undergo relatively normal gastrulation
demonstrate OT of variable lengths from mild (B) to moderate and
severe (C,D) when compared with control at E9.5 (A). OT, outflow tract;
V, ventricle; 1, first pharyngeal arch.
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Later, between E9.0 and E10.5, Fgf8 mRNA is expressed in the
pharyngeal endoderm and ectoderm in close proximity to the AHF,
but not detected in the SM or OT (Fig. 2E,E,G,I). By contrast, -
gal activity is still detected within the SM and extensively in the OT
and RV (Fig. 2F,F,H). To better define which cells are expressing
lacZ, we sectioned whole-mount stained embryos at multiple stages.
Transverse sections at E8.0 demonstrate expression within the SM
extending from the OT myocardium caudally to where the foregut
has not closed (Fig. 2K1-K3). In addition, we detect expression at
E9.5-E10.0 in the central area of the developing first and second
pharyngeal arch, consistent with non-neural crest CM (Fig. 2F,L,L).
These Fgf8lacZ-positive CM cells are contiguous with the developing
OT wall.
To determine the nature of the discrepancy between Fgf8 mRNA
expression and Fgf8lacZ -gal activity, we analyzed the OT of the
heart at E9.5 for lacZ mRNA. Although, lacZ mRNA was detectable
by in situ hybridization in domains of Fgf8lacZ -gal activity (Fig.
3A,B), the mRNA levels appear much lower in proportion to protein
activity. Additionally, very low levels (<1% of limb expression) of
Fgf8 message are detected in the OT by RT-PCR (Fig. 3C), which
again are out of proportion with -gal activity. This finding suggests
that most of the activity in OT and RV myocardium is the result of
residual -gal protein carried within cells that originated from the
AHF external to the developing heart tube, consistent with AHF
development models.
Given the expression of Fgf8lacZ within the SM and CM, and the
cardiac defects associated with Fgf8 hypomorphic mutants, we
hypothesized that Fgf8 expression is required within the AHF for
the development of the OT and RV. To test this hypothesis, we
performed genetic ablation of Fgf8 using the tissue-specific Cre
lines Nkx2.5Cre and TnT-Cre.
Nkx2.5Cre, but not TnT-Cre, mediates ablation of
Fgf8 in the AHF
The Nkx2.5 locus targets most cardiogenic populations when
expressing Cre (Moses et al., 2001; Stanley et al., 2002); however,
early cardiac crescent expression of the Nkx2.5Cre allele used in this
study is somewhat mosaic (data not shown). Nevertheless, complete
recombination in the cardiogenic fields is observed at E8.0-E8.5 prior
to heart tube elongation (Fig. 4B,B). Although mesodermal
expression of Fgf8 precedes robust Nkx2.5Cre expression, we can use
the Nkx2.5Cre allele to ablate Fgf8 in the AHF prior to the elongation
process. Nkx2.5Cre also targets cells in the heart tube, the ventral
pharyngeal endoderm and the anterior ectoderm of the first
pharyngeal arch (Fig. 4B,B,E,E,E). As revealed by the Fgf8lacZ
line, Fgf8 is expressed in the pharyngeal endoderm, ectoderm, the
AHF and the lineage of the AHF (Fig. 4A,A,D,D,D). Therefore,
Fgf8 will functionally be ablated from the AHF, endoderm, first
pharyngeal arch ectoderm and subsequent derivatives of these tissues.
By contrast, TnT-Cre drives DNA recombination in the primary
heart field cardiac crescent as early as E7.5, but not in the AHF
precursors (Jiao et al., 2003). Between E8.5 and E11.5, the expression
domain is exclusive to the entire myocardium including OT,
ventricles and atria. Importantly, TnT-Cre is expressed in AHF
derivatives only after these cells have migrated into the heart tube
proper and differentiated to form the OT and RV myocardium
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Fig. 2. Comparison of Fgf8 mRNA
expression and Fgf8lacZ -gal activity
relative to AHF development. (A) Fgf8
mRNA, as seen by in situ hybridization, is
expressed in the presumptive AHF, but not
the primary (1o) heart field (arrow) as early
as E7.75. (B,D,F,H,J) Fgf8lacZ expression, as
seen by -gal activity, is observed in AHF
cells from E7.75 through E10.5 in whole
mount. (C,C) Expression is later seen in the
OT and the contiguous SM at E9.0 in
whole-mount (C) and mid-sagittal section
(C). Fgf8 mRNA levels in the OT and SM
become reduced at E9.5 (E,E), and is no
longer detectable in AHF cells at E10.5
(G,I). Fgf8lacZ expression at E8.5 in whole-
mount (K) and in transverse sections (K1-
K3). -Gal activity is noted in the SM (black
arrowheads) and in the outflow tract (OT).
Mid-sagittal sections of Fgf8lacZ embryos
reveal -gal activity in the PE and SM at
E9.0. At E9.5, -gal activity is noted in the
SM and OT (F). At E10.0, Fgf8lacZ-positive
cells are observed in the pharyngeal CM in
whole mount (L) and in coronal section (L),
which are contiguous with the OT. OT,
outflow tract; SM, splanchnic mesoderm;
CM, core mesoderm; PE, pharyngeal
endoderm; LV, left ventricle; SV, sinus
venosus.
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(Fig. 4C,C,F-F). TnT-Cre is not expressed in the endoderm.
Comparisons of both lateral and medial sections of Fgf8lacZ,
Nkx2.5Cre; R26R and TnT-Cre; R26R at E9.5 demonstrate the relevant
overlapping domains of expression (Fig. 4D-F,D-F,D-F).
We defined the regions of functional Fgf8 deletion by RNA in situ
hybridization for the deleted exons of the Fgf8flox allele (Fig. 4G-J).
We confirmed that Fgf8 expression is greatly reduced in the AHF of
Nkx2.5Cre/+; Fgf8flox/– embryos as early as E8.0 (compare Fig. 4G
with 4H) and virtually absent by E9.5 (compare Fig. 4J with 4I),
while maintained in other areas of expression such as brain, surface
ectoderm and tail bud (where Nkx2.5Cre is not expressed).
Conversely, TnT-Cre recombination resulted in no discernable
change in Fgf8 mRNA expression in the SM or endoderm (data not
shown). Phenotypic comparison between TnT-Cre; Fgf8flox/–
embryos and Nkx2.5Cre/+; Fgf8flox/– mutants identify and define the
domains of Fgf8 expression that are necessary for OT and RV
development.
Nkx2.5Cre, but not TnT-Cre, mediated deletion of
Fgf8 results in OT/RV truncation and pharyngeal
arch hypoplasia
We obtained the expected ratio of Nkx2.5Cre/+; Fgf8flox/– class
embryos at stages up to E9.5. However, at later time points, we
observed a marked reduction in the number of mutant class
embryos with no surviving mutants after E10.5. By gross
morphology at E9.5, mutant embryos exhibit severely truncated
heart tubes and hypoplastic pharyngeal arches (Fig. 5). Using a
general marker of specified myocardium (myosin heavy chain,
Mhc), the left ventricle and both atria appear grossly normal,
although slightly dilated, while the presumptive OT and RV are
almost completely absent (Fig. 5A,B). Only a small segment of
myocardium joins the left ventricle to the aortic sac. To better
define the regions of heart tube that are missing, we performed in
situ hybridization analysis on the Nkx2.5Cre/+; Fgf8flox/– mutants
and littermate controls with a number of regionally specific
markers (Fig. 5C-J). Wnt11, previously described as a
marker specific for the truncus of the OT of the heart (Cai et
al., 2003), is completely absent, indicating that mutants are
deficient in this region of the OT (Fig. 5C,D). We used the
chamber-specific markers atrial natriuretic factor (Anf) and myosin
light chain 2v (Mlc2v) to further characterize the remnant anterior
heart segment. Anf specifically marks the left ventricle and both
atria at E9.5 (Fig. 5E) (Christoffels et al., 2000), while Mlc2v is
specifically expressed by ventricular myocardium (Fig. 5G) (Cai
et al., 2003). We observe in our Nkx2.5Cre/+; Fgf8flox/– mutants that
the small anterior heart segment does not express Anf (Fig. 5F), but
does express Mlc2v (Fig. 5H). This analysis suggests that the
remnant region is primarily residual right ventricular myocardium,
with very little contribution by OT myocardium.
As a final means to characterize the mutant heart tubes, we bred
the Bmp4lacZ ‘knock in’ allele onto wild-type and mutant
backgrounds, and stained the embryos for -gal activity. In wild-
type controls, Bmp4lacZ is expressed in the SM, the OT and at low
levels in the RV, but is not expressed in left ventricle or the atria (Fig.
5I) (Jiao et al., 2003). In Nkx2.5Cre/+; Fgf8flox/– mutants, very few
lacZ-expressing cells are present in the small heart segment,
supporting the hypothesis that this region is reduced residual RV
(Fig. 5J). The sum of these data indicates that primarily the OT and
much of the RV are deficient in these mutant embryos. These are the
tissues that derive from the AHF.
Our earlier analysis of both Fgf8 mRNA and lacZ expression
reveals low levels in the OT of the heart tube itself. To ascertain any
functional role for Fgf8 expression within the specified myocardium
itself rather than the AHF cells, we used the heart tube-specific TnT-
Cre line. As predicted by our hypothesis, TnT-Cre mediated ablation
of Fgf8 does not result in any discernable OT or RV defects when
examined at E10.5 (n=15) or OT septation defects at term. In fact,
TnT-Cre; Fgf8flox/– embryos are viable. This finding not only
indicates that Fgf8 expression is dispensable in the myocardium of
the differentiated heart tube, but it further suggests that the crucial
regions of Fgf8 expression for heart tube elongation include the
AHF and/or the pharyngeal endoderm. These are regions of
Nkx2.5Cre expression not inclusive of the TnT-Cre domain. However,
these data do not rule out that OT myocardium could still be
responding to FGF8 signals originating from the AHF or pharyngeal
endoderm.
The Nkx2.5Cre lineage is reduced in the Nkx2.5Cre/+;
Fgf8flox/– mutants
As Nkx2.5Cre is expressed in the AHF, we can use the Cre reporter
line R26R (Soriano, 1999) to trace the fate of these cells. Using this
strategy, we analyzed the Nkx2.5Cre lineage in the Fgf8 conditional
mutant background. At stages prior to heart tube elongation (E8.0),
we do not observe any change in the number of R26R lacZ-
expressing cells of Nkx2.5Cre/+; Fgf8flox/–; R26R mutants. However,
differences become noticeable by E8.5-E9.0 as the AHF cells move
from the SM and into the heart tube (Fig. 6A,B). By E9.0-E9.5, we
observe a significant reduction in -gal-positive cells in the SM
(Fig. 6C-H) and the pharyngeal endoderm (Fig. 6E,F), evidenced
by the severe thinning of these cell layers (Fig. 6E,F). -gal-
positive cells of the CM are also significantly decreased in mutants
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Fig. 3. Fgf8lacZ expression reflects endogenous Fgf8 expression.
-Gal activity in Fgf8lacZ/+ embryos at E9.5 (A) is detected in the OT and
RV, and areas of normal Fgf8 mRNA expression, such as the brain. -
Gal activity correlates with the expression of lacZ mRNA seen in whole
mount in situ hybridization at E9.5, but very low levels are seen within
the OT and RV (B). Fgf8 transcripts are present in the OT at very low
levels compared with limb bud controls and HPRT positive controls (C)
shown by semi-quantitative RT-PCR analysis at E9.5. These data suggest
that Fgf8lacZ expression accurately reflects Fgf8 mRNA expression and
that -gal activity is more prominent in OT/RV than either lacZ or Fgf8
mRNA. OT, outflow tract; LB, limb bud; NEG, negative control tissue.
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(Fig. 6G,H). The overall reduction in the Nkx2.5Cre lineage strongly
suggests that loss of these cells results in the severe heart tube
truncation phenotype that is observed in Fgf8 conditional mutants.
Fgf8lacZ cells are reduced, but not completely
absent in mutants
As Fgf8lacZ also marks AHF cells, we used the Fgf8lacZ allele
as a null allele in our ablation scheme to determine the fate
of Fgf8-expressing cells in Nkx2.5Cre/+; Fgf8lacZ/flox mutant
embryos. Phenotypically, Nkx2.5Cre/+; Fgf8flox/lacZ embryos are
indistinguishable from Nkx2.5Cre/+; Fgf8flox/– embryos. As seen in
whole-mount and section, the overall number of Fgf8lacZ-positive
cells in the conditional mutants is mildly reduced (Fig. 6J), and, as
expected, ectodermal expression remains intact. Again, as seen with
the Nkx2.5Cre lineage, we observe a loss of AHF cells as shown by
the thinning of the SM cell layer (Fig. 6J). Interestingly, most of the
AHF cells that remain in the SM and CM are Fgf8lacZ -gal-positive
(Fig. 6J,J).
We also observe that the OT/RV cells in Nkx2.5Cre/+; Fgf8lacZ/flox
mutants are Fgf8lacZ positive. Although consistent with our data
indicating that this segment is remnant RV, this finding is surprising
in that we expected a lineage autonomous function of Fgf8, i.e. that
deletion of Fgf8 would result in a loss of all the Fgf8lacZ-expressing
cells of the heart tube. There are several explanations for the
persistence of Fgf8lacZ-expressing cells in Nkx2.5Cre/+; Fgf8lacZ/flox
embryos. First, this subset of AHF cells may develop independently
of Fgf8. Second, deletion of Fgf8 by Nkx2.5Cre may not be early
enough to affect a small population of AHF as Fgf8 expression
precedes Nkx2.5 expression. Alternatively, residual RNA or protein
after genetic deletion can result in some functional rescue of the
earliest AHF cells, which form the RV. The latter two explanations
are more likely given that at early stages, R26R data clearly
demonstrates a relatively normal number of Nkx2.5-positive cells of
the AHF, and residual Fgf8 mRNA is observed in mutants (Fig. 4H,
Fig. 6B) despite complete recombination between E8.0 and 9.5 (Fig.
4C,E,E and data not shown).
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Fig. 4. Tissue-specific ablation studies using Nkx2.5Cre and TnT-Cre lines. Fgf8lacZ expression at E8.5 (A,A) overlaps with expression of
Nkx2.5Cre in the OT, SM and PE (B,B). Additionally, Nkx2.5Cre and Fgf8lacZ expression coincides in the CM at E9.5 (D-D compared with E-E). TnT-
Cre expression overlaps with Fgf8lacZ only in the OT myocardium (C,C,F-F). Noted domains of Nkx2.5Cre recombination that coincide with Fgf8lacZ
include the OT, SM, CM and lateral PE, but not surface ectoderm [except for first arch (D,D,E,E and data not shown)]. In situ hybridization
analysis for Fgf8 was performed at E8.5 (G,H) and E9.5 (I,J) to confirm genetic ablation in these regions with residual expression in the ectoderm.
Fgf8 mRNA is markedly reduced in the mutants (H,J) compared with normal controls (G,I). OT, outflow tract; SM, splanchnic mesoderm; PE,
pharyngeal endoderm; A, atria; V, ventricles.
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Erk phosphorylation is reduced in Nkx2.5Cre/+;
Fgf8flox/– mutants
FGF8 can function through the receptor tyrosine kinase pathway,
leading to the phosphorylation of the MAP kinase Erk (Corson et al.,
2003; Katz and McCormick, 1997; Rommel and Hafen, 1998; Sato
and Nakamura, 2004). Distribution of phospho-Erk (pErk) can
therefore identify tissue targets undergoing active signaling as a
result of Fgf8 activity in anterior heart development. We first observe
pErk staining in the SM at E8.5 (data not shown). pErk persists until
E9.0, where it is observed in the SM as well as the emerging OT, but
not significantly in the pharyngeal endoderm (Fig. 7A,A). After
E9.5, when AHF cells have been added and looping is complete,
there is an absence in pErk staining in the SM and OT, indicating
absence of active signaling through this pathway (data not shown).
This decrease in Erk phosphorylation temporally coincides with the
observed downregulation of Fgf8 mRNA, suggesting that Fgf8
signals through Erk in the AHF. If this hypothesis is correct, then
loss of Fgf8 will result in the loss of Erk phosphorylation in the SM.
We therefore compared the pErk levels in wild-type and Nkx2.5Cre/+;
Fgf8flox/– mutant embryos.
In early cardiac crescent stages, there is no detectable difference
in pErk levels between wild-type and mutant embryos (data not
shown). This finding is consistent with the fact that at these early
stages, Nkx2.5Cre expression appears low and incomplete, as revealed
by the R26R reporter gene. Between E8.5 and E9.5 as the heart tube
undergoes elongation, Nkx2.5Cre/+; Fgf8flox/– embryos do not stain
positively for pErk in the SM, indicating a loss of signal specifically
within these AHF cells (Fig. 7B,B). It therefore appears that Fgf8
signaling through Erk phosphorylation within the SM is necessary
for AHF addition to the myocardium.
Genetic targets Pea3 and Bmp4 are reduced in
Nkx2.5Cre/+; Fgf8flox/– mutants
To further test our hypothesis that FGF8 signals in an autocrine
fashion to the AHF, we analyzed downstream genetic components
of the Fgf8 pathway. Members of the ETS family of transcription
factors, Pea3, Erm and Er81, are transcriptional targets of FGF8
signaling (Corson et al., 2003; Munchberg and Steinbeisser, 1999;
Raible and Brand, 2001; Roehl and Nusslein-Volhard, 2001). Pea3
is expressed in the SM, the CM and the pharyngeal ecto- and
endoderm, suggesting a role for pharyngeal arch and AHF
development (Fig. 7C). Genetic ablation of Fgf8 within the
Nkx2.5Cre domain results in a significant decrease in Pea3 expression
in the first arch (Fig. 7C,D) as well as undetectable expression within
the SM and pharyngeal endoderm (Fig. 7C,D). This result provides
functional evidence that this Ets transcription factor is a downstream
target of FGF8 within these tissues. Interestingly, we did not detect
expression of activated pErk within the endoderm in wild-type
embryos. Pea3 is expressed in both tissues in wild-type embryos,
and is absent in both tissues after Fgf8 ablation. These data suggest
that FGF8 may signal directly to the SM to activate Erk, and that
a secondary signal (independent of Erk) may be transduced both in
an autocrine fashion to the SM and by a paracrine mechanism to the
endoderm to initiate Pea3 expression. Alternatively, FGF8 could
regulate Pea3 expression independently of Erk activation.
In consideration of the potential crosstalk between the AHF and the
pharyngeal endoderm, we determined if Fgf8 ablation altered other
extracellular signaling pathways (Shh and Bmp4) known to be
involved in OT development (Liu et al., 2004) (Washington Smoak et
al., 2005). We do not observe any alterations of Shh expression in the
endoderm of Nkx2.5Cre/+; Fgf8flox/– mutants (Fig. 7G,H). Ptch1lacZ
expression, which is upregulated in response to activation of the
hedgehog pathway (Goodrich et al., 1996), is likewise unaltered in the
endoderm and SM (Fig. 7E,E,F,F). However, examination of
Bmp4lacZ expression in the SM of Nkx2.5Cre/+; Fgf8flox/– mutants (Fig.
7I,J and Fig. 5J) indicates a reduction in gene expression. These data
reveal that Fgf8 does not regulate the hedgehog pathway in the SM,
but may regulate Bmp4. In addition, they suggest that the loss of pErk
and Pea3 expression are indeed the result of Fgf8 ablation and not the
result of dysplastic SM and endoderm, as these tissues are still capable
of expressing Ptch1 and Shh, respectively.
Fgf8 is required for proliferation and survival of
the precardiac mesoderm and pharyngeal
endoderm
Lineage tracing of the Nkx2.5Cre domain has revealed a reduction
in both the endoderm and SM populations. Therefore, we
analyzed cell proliferation in the pharyngeal regions from E8.5 to
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Fig. 5. The anterior heart is truncated in Nkx2.5Cre/+; Fgf8flox/– mutants. Analysis of normal (A,C,E,G,I) and mutant (B,D,F,H,J) embryos at E9.5
was performed by whole mount in situ hybridization (A-H) or lacZ stain (I,J) for the genes as indicated. Mhc is expressed in the myocardium. Wnt11
is normally expressed in the OT (C, black arrowhead), but is not expressed in mutants (D, white arrowhead). The boundary of Anf expression in
mutants (E,F, black arrowhead) is in close proximity to the aortic sac, indicating virtual absence of OT/RV. Mlc2v-negative myocardium of the
proximal OT (G, black bracket) is absent in the mutant (H, white arrowhead). Bmp4lacZ-expressing cells are essentially absent in the OT (J, white
arrowhead) and splanchnic mesoderm (J, white bracket) compared with normal controls (I, black brackets). 1, first pharyngeal arch; OT, outflow
tract; LV, left ventricle; RV, right ventricle; A, atrium.
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E9.5 using antibodies for phosphorylated histone H3 (pHH3),
which marks mitotic cells. In Nkx2.5Cre/+; Fgf8flox/– mutants, we
have observed a significant decrease in cell proliferation in both
the SM and pharyngeal endoderm (Fig. 8A,B). A comparison of
wild-type and mutant embryos reveals that mitotic indices are
reduced by ~50% in the SM and by 60% in the pharyngeal
endoderm, although no significant differences in mitotic indices
were noted in the outflow region, the left ventricle, atria (Fig. 8G)
or the pharyngeal arches (data not shown).
LysoTracker Red analysis from E8.5 to E9.5 reveals that
the SM and surrounding tissue undergo excess cell death.
Specifically at E9.0, there is an increase in cell death in the SM
immediately distal to the emerging OT (Fig. 8C,D), as well as
the endoderm adjacent to the SM. By E9.5, once heart tube
elongation has been completed, no differences are detected
in the SM. However, excess cell death has expanded into the
ventral pharyngeal endoderm (data not shown). These data,
along with the proliferation studies, reveal that Fgf8 is necessary
for the expansion and maintenance of the precardiac mesoderm,
as well as pharyngeal endoderm, and suggest that the truncation
of the OT and RV is a result of the reduction in these cell
populations.
Neural crest cells undergo excess cell death in
Nkx2.5Cre/+; Fgf8flox/– mutants
We and others have previously described abnormal cell death of
neural crest cells (NCCs) in Fgf8 hypomorphs (Abu-Issa et al.,
2002; Frank et al., 2002). Interestingly, tissue-specific ablation of
Fgf8 in the Nkx2.5Cre domain also results in excess cell death of
NCCs in the pharyngeal arch mesenchyme at E9.5 (Fig. 8E,F). The
excess cell death in the pharyngeal arch mesenchyme encompasses
much of the migratory streams of NCCs up to the dorsal neural
tube. These migratory NCCs are specified and migrate in relatively
normal streams from the dorsal neural tube as seen by the markers
Ap2 and Crabp1 (data not shown). In addition, we see increased
cell death of presumptive cardiac NCCs in close proximity to the
OT (Fig. 8D).
DISCUSSION
FGF8 signaling to the AHF is required for OT and
RV development
In this study, we identify Fgf8 expression domains that are required
for the maintenance and specification of the AHF. Elimination of
the Fgf8 gene specifically from the Nkx2.5Cre domain results in
aberrant AHF development and ultimately OT/RV truncation. By
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Fig. 6. Nkx2.5Cre lineage and Fgf8lacZ-
expressing cells are reduced in Nkx2.5Cre/+;
Fgf8flox/–; R26R and Nkx2.5Cre/+; Fgf8flox/lacZ
mutants, respectively. (A-F) Whole-mount
Nkx2.5Cre lineage analysis from E8.5 to E9.5
indicates a drastic reduction of lacZ-positive
cells in the mutant class (B,D,F, black
arrowheads) when compared with normal
controls (A,C,E, black brackets). Histological
sections at E9.5 (E,F) reveal a reduction of
the Nkx2.5Cre lineage in the pharyngeal
endoderm (PE) in addition to the splanchnic
mesoderm (SM), both of which are thinned
with apparent reduced cell number. Ventral
views (G,H) clearly demonstrate the reduction
of the Nkx2.5Cre lineage in the CM and SM.
Fgf8lacZ-positive cells are also markedly
reduced, but present, in SM and OT in the
mutant class at E9.5 (J,J) compared with
controls (I,I). Pharyngeal arches are referred to
by their respective numbers (1, 2, 3/4); OT,
outflow tract; LV, left ventricle; CM, core
mesoderm; V, ventricle.
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contrast, our studies using TnT-Cre demonstrate that Fgf8
expression in the entire primary and AHF-derived myocardium is
not crucial. No obvious defects are noted in primary heart field
development with either Nkx2.5 or TnT-Cre ablations, suggesting
that Fgf8 expression is not required in these tissues within the time
frame of the Cre expression. Therefore, Fgf8 expression must be
required in the AHF and/or the pharyngeal endoderm for OT/RV
outgrowth and elongation. Interestingly, Fgf8 ablation in all
mesoderm, but not endoderm, can phenocopy Nkx2.5Cre/+; Fgf8flox/–
embryos (Park et al., 2006). Although these data suggest that Fgf8
expression in the SM alone is required for heart tube elongation,
this phenotype (driven by Mesp1Cre) could represent an earlier
defect in mesodermal specification and/or maintenance. Erk
phosphorylation is restricted to the SM, and not endoderm,
demonstrating that FGF8 signaling to the AHF is crucial for OT/RV
outgrowth and development.
Other studies have also used tissue-specific gene deletion to
determine the specific functions of the various Fgf8 expression
domains in the pharynx. Tbx1-Cre, like Nkx2.5Cre, is expressed in
both pharyngeal endoderm and mesoderm. Tbx1-Cre ablation of
Fgf8 results in DiGeorge-like defects reminiscent of late term Fgf8
hypomorphs (Brown et al., 2004), but the majority of these mutants
do not exhibit the early heart tube truncation phenotype seen in
Nkx2.5Cre/+; Fgf8flox/– embryos. As Nkx2.5Cre is a null allele, and
Nkx2.5 may lie genetically downstream of Fgf8 (Alsan and
Schulthesis, 2002), Nkx2.5 heterozygosity may contribute to early
OT/RV truncation. However, the Nkx2.5Cre/+; Fgf8flox/– mutants can
be phenocopied through the use of other Cre lines, such as Isl1Cre
(Park et al., 2006). Furthermore, we observe the heart tube truncation
phenotype in Fgf8 hypomorphs where Nkx2.5 gene dose is
unaltered.
Phenotypic differences between Nkx2.5Cre/+; Fgf8flox/– embryos
and Tbx1-Cre; Fgf8flox/– embryos may be the result of slightly
different Cre expression domains. Brown et al. have shown that
DNA recombination in the endoderm is complete at E10.5, but the
extent of endodermal Tbx1-Cre expression at earlier stages may not
be complete (C. Brown, personal communication). Incomplete
deletion of Fgf8 in the endoderm earlier in development may explain
the discrepancy between Tbx1-Cre; Fgf8flox/– and Nkx2.5Cre/+;
Fgf8flox/– mutants. This explanation suggests a crucial role for
early endodermal Fgf8 expression and AHF expression in the
development and outgrowth of the OT/RV. In support of this
hypothesis, Fgf8 ablation specifically in the AHF does not
phenocopy the early heart tube truncation phenotype (Park et al.,
2006). These data, therefore, suggest a requirement for both domains
of Fgf8 expression for heart tube elongation. Although it remains
unclear whether or not endodermal and mesodermal sources of
FGF8 have separate and distinct functions, we have nevertheless
shown that Fgf8 has a role in determining the length of the OT/RV
through proliferation and survival of the AHF.
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Fig. 7. Cell signaling analysis in Nkx2.5Cre/+; Fgf8flox/– mutants. Immunohistochemistry analysis demonstrates pErk is localized in the SM, but
not the PE (A,A). Nkx2.5Cre elimination of Fgf8 results in loss of pErk from the SM (B,B). RNA in situ hybridization demonstrates that Pea3 is
expressed in the developing arches as well as SM and PE (C,C). Loss of Fgf8 results in continued arch ectoderm expression (D, black arrowhead) but
loss of SM and PE expression (D). Ptch1lacZ -gal activity (E-F) and Shh expression (G,H) demonstrate that the SM and PE are still capable of Ptch1
expression, and that Fgf8 does not regulate this pathway in these tissues. Bmp4 is downregulated within the SM (I,J), suggesting a requirement for
FGF8 signaling. OT, outflow tract; SM, splanchnic mesoderm; PE, pharyngeal endoderm; Nt, neural tube/notochord.
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It is interesting to speculate that the OT septation defects seen
in near term Fgf8 hypomorphic embryos, such as double outlet
right ventricle, may reflect alignment defects owing to variable
lengthening of the OT. However, it is also possible that alterations
in the number or specification of cardiac NCCs entering the OT
could also account for such defects. NCCs also have a role in OT
elongation as NCC laser ablation results in shortened OT in chick
(Farrell et al., 2001; Yelbuz et al., 2002). Distinguishing between
such possibilities will be difficult because of potential interactions
between the two fields. We are currently investigating the
requirement for the Fgf receptor genes Fgfr1 and Fgfr2 in the
AHF to determine if Fgf signaling has a direct influence on AHF
development. Preliminary data indicate that loss of these receptors
from the Nkx2.5Cre domain results in OT septation defects, but not
OT/RV truncation (G. Smyth and E.N.M., unpublished).
Neural crest cells and the anterior heart field
Expansion of the pharyngeal arches is the result of NCCs migrating
into the pharyngeal region, forming much of the mesenchyme. Loss
of Fgf8 from the AHF and endoderm results in marked cell death of
migratory NCCs (Fig. 8F), similar to that seen in Fgf8neo/– embryos
(Abu-Issa et al., 2002; Macatee et al., 2003). This expansive cell
death can account for the pharyngeal arch hypoplasia observed in
Fgf8 mutants. It was surprising to observe that NCCs located as far
as the dorsal neural tube undergo excess cell death in Nkx2.5Cre/+;
Fgf8flox/– embryos. This observation leads to two hypotheses. First,
given the close apposition and function of the AHF and NCCs in OT
development, it is possible that the AHF and NCCs are
interdependent. That is, the development of the NCCs depends on
signals from the AHF (perhaps through Bmp4). Defective AHF,
owing to loss of Fgf8, negatively impacts NCC development
indirectly. It follows then that pharyngeal arch hypoplasia would
result from the loss of NCCs.
The second possibility is that FGF8 protein from the AHF is able
to diffuse long distances to directly influence NCC development.
However, NCC-specific deletion of both Fgfr1 and Fgfr2 does not
affect cardiac NCC development, suggesting an indirect effect of
FGF8 on these cells in the lower arches (G. Smyth and E. Meyers,
unpublished). Alternatively, FGF8 may signal directly to the NCCs
through other Fgf receptors.
Role of the pharyngeal arch core mesoderm
Interestingly at E9.5, Fgf8lacZ -gal activity persists within the CM
of the pharyngeal arches, but neither Fgf8 nor lacZ mRNA
transcripts are detected (data not shown). Previous work has shown
that this population of cells is derived from the paraxial mesoderm
(Trainor et al., 1994), and Fgf8 appears to be expressed in this region
as early as E8.0 (Crossley and Martin, 1995). The persistence of -
gal activity again could represent a lineage trace of this mesoderm
into the core of the pharyngeal arches rather than nascent gene
expression.
Gross analyses of the AHF markers Fgf10lacZ, Tbx1lacZ and
Fgf8lacZ, as well the Nkx2.5Cre lineage trace, reveal that the CM cells
are contiguous with the OT (Brown et al., 2004; Kelly et al., 2001).
DiI-labeling studies suggest that these CM cells are part of the AHF,
and contribute cardiomyocytes to the OT at early stages (Kelly et al.,
2001). We have found that like in the SM, there is a marked
reduction of the Nkx2.5Cre-positive cells in the CM of conditional
Fgf8 mutants. The reduction of CM may not only contribute to
OT/RV truncation, but also to pharyngeal arch hypoplasia.
Additionally, Fgf8 expression may be required in the CM for the
survival of the NCCs that populate the pharyngeal arches.
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Fig. 8. Cell proliferation and survival are reduced in Nkx2.5Cre/+;
Fgf8flox/– mutants. Cell proliferation rates at E9.0 were assessed in
section by anti-phospho-histone H3 immunostaining (red) in normal (A)
and mutant embryos (B). SYTO13 counterstain (green) marks nuclei.
Marked reduction in proliferation was noted in the PE and SM of
mutants compared with controls (n=3 and 4, respectively). Statistical
analysis indicates that decreases in cell proliferation in the PE and SM
were significant (P<0.05), while rates in the OT, RV, LV and atria were
unaltered (G). LysoTracker Red staining at E9.0 in normal (C) and
mutant (D) embryos in confocal optical sections (white signal indicates
cell death). Increases in cell death are observed in the SM contiguous
with the outflow tract (OT) of mutant embryos. Additionally, increases
in cell death are observed in the PE at the level of the OT. LysoTracker
Red staining at E9.5 (E,F; red signal indicates cell death) demonstrate
that mutant embryos (F) have excess death of NCCs in the pharyngeal
arches (1,2). Embryos were counterstained with anti-AP2 (green). OT,
outflow tract; SM, splanchnic mesoderm; PE, pharyngeal endoderm;
RV, right ventricle; LV, left ventricle; O, otocyst; E, eye.
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At E9.5, when heart tube elongation has been completed, we
observe a persistence of Fgf8lacZ and Nkx2.5Cre-positive cells in
the CM. Although these cells remain contiguous with the OT
myocardium, it is unlikely that at this stage they continue to
contribute to the OT. Instead, these cells are known to give rise to the
muscles of the jaw (Trainor et al., 1994). It is intriguing to speculate
that OT/RV myocardium and the muscles of the jaw arise from a
common lineage represented by the Fgf8lacZ allele and Nkx2.5Cre
line. At the least, the two populations share common genetic
regulators required for myogenesis and/or for proper development,
such as Tbx1, Isl1 and Nkx2.5 (Cai et al., 2003; Kelly et al., 2004;
Lyons et al., 1995).
Cellular functions of Fgf8 in the anterior heart
field
Aside from cell proliferation and survival, FGF8 signaling has a
very specific role in gene regulation. FGF8 signaling has been
shown to modulate the expression of Wnt (Grieshammer et al.,
2005) and Bmp (Lewandoski et al., 2000) genes to pattern the
embryo. Fgf8 has also been shown in vivo to be necessary for
expression of various transcription factors such as Pea3, Erm and
Tbx2 (Firnberg and Neubuser, 2002; Munchberg and Steinbeisser,
1999; Raible and Brand, 2001; Roehl and Nusslein-Volhard, 2001).
Here, we have found that Fgf8 is necessary for Pea3 expression
within the AHF itself, and may also modulate Bmp4 expression
levels.
Many ETS and Fgf proteins have roles in epithelial-to-
mesenchymal transition and cell migration (reviewed by Hsu et al.,
2004; Thiery, 2002). Fgf1 and Fgf2 have been shown in vitro to
induce the internalization and nuclear localization of the cell-
adhesion molecule E-cadherin (Bryant et al., 2005). In addition, Fgf
signals can activate cell motility through the small GTPase Rho, as
seen in Drosophila (Schumacher et al., 2004), and through activated
Mapk to promote myosin light chain kinase phosphorylation
(Klemke et al., 1997). Developmentally, the loss of the Fgf ligand
heartless in Drosophila demonstrates defects in mesodermal
migration (Beiman et al., 1996). In mouse, Fgf8-null (Sun et al.,
1999) and Fgfr1-null embryos (Ciruna and Rossant, 2001) have
altered cadherin expression, and exhibit migrational defects during
gastrulation. We speculate that Fgf8 signaling in the AHF increases
cell motility at both the transcriptional and cellular levels, allowing
for the migration of cells into the heart tube. Loss of this motility
signal may disrupt the AHF program, resulting in increased cell
death and decreased proliferation. Studies are currently under way
to address this possibility.
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